One of the duodenoscope manufacturers at the center of a series of infectious outbreaks dating back to 2012 has announced plans to recall its current model and replace it with a new FDA-approved design.
On February 19, the Food and Drug Administration (FDA) announced that reprocessing instructions for Pentax duodenoscopes had been validated and approved by the agency.
A new report by the United Kingdom’s Review on Antimicrobial Resistance (RAR), says drug-resistant superbugs can be fought with global coverage and research of vaccines.
Today’s free resource comes from Verify and Comply, Sixth Edition. This book includes credentialing and medical staff standards and regulations for the most popular...
Building on its Comprehensive Unit-based Safety Program (CUSP), the U.S. Department of Health and Human Services Agency for Healthcare Research and Quality (AHRQ) recently released a new toolkit aimed at reducing catheter-associated urinary tract infections (CAUTI) in hospitals.
During this year’s World Economic Forum in Switzerland, drug companies from 16 different nations announced a new agreement to fight the rise of antimicrobial-resistant (AMR) infections, sometimes referred to as “superbugs.”
Fujifilm Medical Systems issued revised reprocessing instructions late last month for Model ED-530XT duodenoscopes, according to a safety communication issued by the Food and Drug Administration (FDA).
A new Senate committee report has tripled the number of confirmed Olympus scope infections to 142. Industrywide, 250 patients have contracted ARIs from duodenoscopes
A new study published in The Journal of the American Geriatrics Society found that infectious diseases are now the leading cause of emergency department (ED) visits by the elderly.
